title: Defining adherence to prophylaxis in haemophilia.
authors.affiliation: Van Creveldkliniek, University Medical Center, Utrecht, The Netherlands.
authors.forename: L H
authors.initials: LH
authors.lastname: Schrijvers
authors.affiliation: Department of Paediatric Haematology, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands.
authors.forename: M H
authors.initials: MH
authors.lastname: Cnossen
authors.affiliation: Haemophilia Treatment Center, Emma Children's' Hospital-Academical Medical Center, Amsterdam, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Beijlevelt-Van der Zande
authors.affiliation: Haemophilia Treatment Center, Emma Children's' Hospital-Academical Medical Center, Amsterdam, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Peters
authors.affiliation: Nursing Science, Faculty of Health Care, University of Applied Science, Utrecht, The Netherlands.|Nursing Science, University Medical Centre, Utrecht, The Netherlands.
authors.forename: M J
authors.initials: MJ
authors.lastname: Schuurmans
authors.affiliation: Van Creveldkliniek, University Medical Center, Utrecht, The Netherlands.|Julius Center for Health Sciences and Primary Care, University Medical Centre, Utrecht, The Netherlands.
authors.forename: K
authors.initials: K
authors.lastname: Fischer
mesh_terms: D003029:Coagulants / Q000627:therapeutic use*; D005169:Factor VIII / Q000627:therapeutic use*; D006395:Hemarthrosis / Q000517:prevention & control; D006467:Hemophilia A / Q000188:drug therapy*; D006801:Humans; D055118:Medication Adherence
chemical_list: D003029:Coagulants; D005169:Factor VIII